Immunotherapy: 424 Real Stories

424 stories match immunotherapy. 352 of them mention chemotherapy.

Joanne, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Joanne's Patient Story

Patient Info: Joanne Sabol, Female, 60s | Stage IV

Metastatic Site: abdomen

More than 2 years after starting pembrolizumab for recurrent Stage IV lung cancer, Joanne had an 81% tumor reduction and continued to feel well while remaining on treatment.

Memorial Sloan Kettering
OutcomeResponding Well
Sonia, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Sonia's Survivor Story

Patient Info: Sonia

She was declared cancer-free in May 2022 and no longer needs medication.

Our Cancer Stories
OutcomeCancer-Free / NED
Nathalie, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Nathalie's Patient Story

Patient Info: Nathalie | Stage IV

Nathalie had been living with stage 4 breast cancer for more than three years and remained focused on time with her children.

Our Cancer Stories
OutcomeLiving With Cancer
Manisha, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Manisha's Patient Story

Patient Info: Manisha

After changing hospitals and completing treatment, Manisha continued to worry about the cancer returning while focusing on her health and family.

Our Cancer Stories
OutcomeNot reported
Michael, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Michael's Patient Story

Patient Info: Michael O’Donnell, Male | Stage IV

More than 5 years after a Stage IV diagnosis, Michael remained on immunotherapy with disease controlled to his and his doctor’s satisfaction and scans every 3 months to watch for growth.

LUNGevity
OutcomeResponding Well
Nina, who was diagnosed with Small Cell Lung CancerLung Cancer

Small Cell Lung Cancer: Nina's Patient Story

Patient Info: Nina, Female

Nina’s tumors began shrinking within weeks of starting trial immunotherapy, and she remained on the trial for 3 years without treatment side effects.

LUNGevity
OutcomeResponding Well
Mary, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Mary's Patient Story

Patient Info: Mary Lynn Moser, Female | Stage IV

Metastatic Site: brain

Mary Lynn wrote this message before her death after nearly 10 years with lung cancer and more than 5 years with brain metastases, while receiving aggressive immunotherapy and chemotherapy.

LUNGevity
OutcomeIn Memory
Bill, who was diagnosed with Stage III Lung CancerLung Cancer

Stage III KRAS Lung Cancer: Bill's Survivor Story

Patient Info: Bill Morris, Male | Stage III

Biomarkers: KRAS

After multimodal treatment, Bill had remained actively cancer-free for more than 3 years and used his experience to support other patients.

LUNGevity
OutcomeCancer-Free / NED
Danielle, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Danielle's Survivor Story

Patient Info: Danielle, Female, 60s | Stage II

Danielle was listed as cancer-free after treatment for Stage II breast cancer that included mastectomy, chemotherapy, 5 weeks of radiation, and immunotherapy.

Fondation ARC
OutcomeCancer-Free / NED
SI
Lung Cancer

Stage IV Small Cell Lung Cancer: Sylvane's Patient Story

Patient Info: Sylvane, Female, 70+ | Stage IV

Metastatic Site: Bone; adrenal glands

After 3 chemotherapy cycles for Stage IV SCLC, Sylvane’s lung tumor had shrunk by half and bone and adrenal metastases had completely regressed, with a final chemo-immunotherapy cycle and then immunotherapy planned.

Cancer et Métabolisme
OutcomeResponding Well
AL
Lung Cancer

Aggressive lung cancer with bone metastases and concurrent localized breast cancer

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: Bone: skull, spine, clavicle

The patient was still receiving carboplatin and Taxol for aggressive lung cancer with bone metastases, while her caregiver reported rapid clinical improvement, pain relief, disappearance of a visible forehead metastasis, and 1 cm reduction in a concurrent localized breast tumor.

Cancer et Métabolisme
OutcomeResponding Well
Cécile, who was diagnosed with Stage IV Kidney/Renal CancerKidney/Renal Cancer

Stage IV Kidney/Renal Cancer: Cécile's Patient Story

Patient Info: Cécile, Female, 50s | Stage IV

Metastatic Site: Lungs

Cécile had primary renal cancer with numerous inoperable lung metastases, entered an immunotherapy clinical trial, and had a good response on the first control scan after 2.5 months.

Vivre avec un Cancer du Poumon
OutcomeResponding Well
Sandra, who was diagnosed with Lung CancerLung Cancer

Lung Cancer: Sandra's Patient Story

Patient Info: Sandra, Female, 40s

Sandra was receiving immunotherapy for lung cancer and described the tumor as responding well and decreasing in size.

Vivre avec un Cancer du Poumon
OutcomeResponding Well
Stephanie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II BRCA1 Invasive Ductal Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie Hargis, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

Stephanie had Stage II triple-negative breast cancer with BRCA1 mutation, then a local recurrence in April 2023 without distant spread; after surgery, chemotherapy, Keytruda, radiation, and Lynparza, she remained in ongoing post-recurrence treatment.

BreastCancer.org (ES)
OutcomeCare Ongoing
Séverine, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Séverine's Survivor Story

Patient Info: Séverine, Female

Séverine described being in remission for 1 year while continuing hormone therapy, after tumorectomy, 6 months of chemotherapy, 18 months of immunotherapy, and bilateral breast removal/reconstruction.

Fondation ARC
OutcomeCancer-Free / NED
Claritza, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Claritza's Patient Story

Patient Info: Claritza, Female, 50s | Stage III

Claritza was living with Stage III breast cancer more than 3 years after diagnosis after her initial plan changed from lumpectomy, chemotherapy, and radiation therapy to immunotherapy and pain medication.

Our Cancer Stories
OutcomeCare Ongoing
Emilcen, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Emilcen's Patient Story

Patient Info: Emilcen, Female, 50s | Stage III

Emilcen was still receiving treatment for Stage III breast cancer more than 3 years after diagnosis, after mastectomy, chemotherapy, radiation therapy, and immunotherapy.

Our Cancer Stories
OutcomeCare Ongoing
Usha, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV Non-Small Cell Lung Cancer: Usha's Patient Story

Patient Info: Usha Jain, Female | Stage IV

Biomarkers: Tumor genetic profile available for navigation review, but specific results are not reported

Stage IV NSCLC after nearly 2 years of chemotherapy and immunotherapy, followed by watchful monitoring with routine scans; clinical trials were reviewed but not pursued.

GO2 Foundation
OutcomeCare Ongoing
Amy, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV Non-Small Cell Lung Cancer: Amy's Patient Story

Patient Info: Amy, Female | Stage IV

Metastatic Site: Neck lymph node; bones — hips, femurs, foot; adrenal…

Living 5 years after Stage IV squamous NSCLC diagnosis, after Keytruda did not work and treatment included bone radiation, SBRT to the lung nodule, and adrenal cryoablation.

Lung Cancer Research Foundation
OutcomeLiving With Cancer
Rhonda, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV EGFR Non-Small Cell Lung Cancer: Rhonda's Patient Story

Patient Info: Rhonda Martin, Female | Stage IV

Biomarkers: EGFR-positive mutation

Metastatic Site: Brain; spine; hip bone; lymph nodes; cerebrospinal…

Rhonda Martin passed away on January 9, 2023 from complications of Stage IV EGFR-positive lung cancer, nearly 5 years after diagnosis in March 2018.

Lung Cancer Research Foundation
OutcomeIn Memory
Nick, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Nick's Survivor Story

Patient Info: Nick Cleworth, Male, 40s | Stage III

Cancer-free after ARTEMIS clinical-trial treatment for node-positive rectal cancer, avoiding surgery and a permanent colostomy.

The Christie NHS
OutcomeCancer-Free / NED
Hatta, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Hatta's Survivor Story

Patient Info: Hatta, Male

No recurrence reported after interventional therapy, biological immunotherapy, Chinese medicine, and local radiotherapy for rectal cancer; later CT report was described as showing no cancer cells, with 8 years of normal life and annual checks.

Modern Cancer Hospital Guangzhou (Colorectal)
OutcomeCancer-Free / NED
Antonio, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Antonio's Patient Story

Patient Info: Antonio, Male, 40s | Stage IV

Metastatic Site: Liver

Improved significantly after cryotherapy, interventional therapy, and bio-immunotherapy for Stage IV sigmoid colon cancer with liver metastasis; no NED/remission statement is reported.

Modern Cancer Hospital Guangzhou (Colorectal)
OutcomeResponding Well
Becky, who was diagnosed with Stage III Lung AdenocarcinomaLung Cancer

Stage III Lung Adenocarcinoma: Becky's Survivor Story

Patient Info: Becky Manning, Female, 40s | Stage III

After surgery, chemotherapy and 8 months of nivolumab on a clinical trial, Becky was no longer on active treatment, had no evidence of disease, felt well, and returned to MSK every 6 months for follow-up.

Memorial Sloan Kettering
OutcomeCancer-Free / NED